Venture Partner at 212 VC, building cross-border dealflow across SF and London. Actively supports and advises high-signal gatherings shaping the future of health, robotics, and AI infrastructure, including the AI & Capital Summit (Berkeley) and MIT’s NANDA Summit.

With over five years in venture capital, has reviewed 10,000+ startups and worked closely with early-stage teams on strategy, fundraising, and go-to-market, with a strong focus on translating deep tech into scalable, real-world impact.

Currently a Newton Fellow at London Business School and part of the Abundance Scholars Program. Focused on building an investment thesis around human longevity and healthspan, exploring the intersection of AI, biology, and proactive healthcare systems.

Mentor across leading accelerator programs and actively involved in founder communities and global startup events, including Istanbul Slush’D, part of the Slush ecosystem.